|
[1]KALAITZAKIS E.Gastrointestinal dysfunction in liver cirrhosis[J].World J Gastroenterol,2014,20(40):14686-14695.
|
|
[2]URRUNAGA NH,ROCKEY DC.Portal hypertensive gastropathy and colopathy[J].Clin Liver Dis,2014,18(2):389-406.
|
|
[3]CHUNG WJ.Management of portal hypertensive gastropathy and other bleeding[J].Clin Mol Hepatol,2014,20(1):1-5.
|
|
[4]NOJKOV B,CAPPELL MS.Distinctive aspects of peptic ulcer disease,Dieulafoy's lesion,and Mallory-Weiss syndrome in patients with advanced alcoholic liver disease or cirrhosis[J].World J Gastroenterol,2016,22(1):446-466.
|
|
[5]MEKAROONKAMOL P,COHEN R,CHAWLA S.Portal hypertensive enteropathy[J].World J Hepatol,2015,7(2):127-138.
|
|
[6]JEON SR,KIM JO.Capsule endoscopy for portal hypertensive enteropathy[J].Gastroenterol Res Pract,2016,2016:8501394.
|
|
[7]ELAMIN EE,MASCLEE AA,DEKKER J,et al.Ethanol metabolism and its effects on the intestinal epithelial barrier[J].Nutr Rev,2013,71(7):483-499.
|
|
[8]AL-BUSAFI SA,McN ABB-BALTAR J,FARAG A,et al.Clinical manifestations of portal hypertension[J].Int J Hepatol,2012,2012:203794.
|
|
[9]HOU Y.The clinical comparision of cirrhosis patients with different etiological upper digestive tract hemorrhage[J].J Clin Exp Med,2015,14(12):999-1001.(in Chinese)侯昀.肝硬化不同病因上消化道出血患者的临床对比[J].临床和实验医学杂志,2015,14(12):999-1001.
|
|
[10] SHARMA M,RAMESHBABU CS.Collateral pathways in portal hypertension[J].J Clin Exp Hepatol,2012,2(4):338-352.
|
|
[11]PILLAI AK,ANDRING B,PATEL A,et al.Portal hypertension:a review of portosystemic collateral pathways and endovascular interventions[J].Clin Radiol,2015,70(10):1047-1059.
|
|
[12]KAPOOR A,DHAREL N,SANYAL AJ.Endoscopic diagnosis and therapy in gastroesophageal variceal bleeding[J].Gastrointest Endosc Clin N Am,2015,25(3):491-507.
|
|
[13]WU Q,SHEN L,CHU J,et al.Characterization of uncommon portosystemic collateral circulations in patients with hepatic cirrhosis[J].Oncol Lett,2015,9(1):347-350.
|
|
[14]QI X,LI H,LIU X,et al.Novel insights into the development of portal vein thrombosis in cirrhosis patients[J].Expert Rev Gastroenterol Hepatol,2015,9(11):1421-1432.
|
|
[15]MASTORAKI A,MASTORAKI S,TZIAVA E,et al.Mesenteric ischemia:pathogenesis and challenging diagnostic and therapeutic modalities[J].World J Gastrointest Pathophysiol,2016,7(1):125-130.
|
|
[16]NORMAN K,PIRLICH M.Gastrointestinal tract in liver disease:which organ is sick?[J].Curr Opin Clin Nutr Metab Care,2008,11(5):613-619.
|
|
[17]DU PLESSIS J,VANHEEL H,JANSSEN CE,et al.Activated intestinal macrophages in patients with cirrhosis release NO and IL-6that may disrupt intestinal barrier function[J].J Hepatol,2013,58(6):1125-1132.
|
|
[18]TELTSCHIK Z,WIEST R,BEISNER J,et al.Intestinal bacterial translocation in rats with cirrhosis is related to compromised Paneth cell antimicrobial host defense[J].Hepatology,2012,55(4):1154-1163.
|
|
[19]ARVANITI V,D'AMICO G,FEDE G,et al.Infections in patients with cirrhosis increase mortality four-fold and should be used in determining prognosis[J].Gastroenterology,2010,139(4):1246-1256,1256.e1-e5.
|
|
[20]FRANCES R,MUNOZ C,ZAPATER P,et al.Bacterial DNA activates cell mediated immune response and nitric oxide overproduction in peritoneal macrophages from patients with cirrhosis and ascites[J].Gut,2004,53(6):860-864.
|
|
[21]KIM BI,KIM HJ,PARK JH,et al.Increased intestinal permeability as a predictor of bacterial infections in patients with decompensated liver cirrhosis and hemorrhage[J].J Gastroenterol Hepatol,2011,26(3):550-557.
|
|
[22] SHUKLA S,SHUKLA A,MEHBOOB S,et al.Meta-analysis:the effects of gut flora modulation using prebiotics,probiotics and synbiotics on minimal hepatic encephalopathy[J].Aliment Pharmacol Ther,2011,33(6):662-671.
|
|
[23]ALBILLOS A,de LA HERA A,GONZALEZ M,et al.Increased lipopolysaccharide binding protein in cirrhotic patients with marked immune and hemodynamic derangement[J].Hepatology,2003,37(1):208-217.
|
|
[24]SANDLER NG,KOH C,ROQUE A,et al.Host response to translocated microbial products predicts outcomes of patients with HBV or HCV infection[J].Gastroenterology,2011,141(4):1220-1230,1230.e1-e3.
|
|
[25]SCHECHTER RB,LEMME EM,COELHO HS.Gastroesophageal reflux in cirrhotic patients with esophageal varices without endoscopic treatment[J].Arq Gastroenterol,2007,44(2):145-150.
|
|
[26]ZHANG J,CUI PL,LV D,et al.Gastroesophageal reflux in cirrhotic patients without esophageal varices[J].World J Gastroenterol,2011,17(13):1753-1758.
|
|
[27]SHARMA M,RAMESHBABU CS.Collateral pathways in portal hypertension[J].J Clin Exp Hepatol,2012,2(4):338-352.
|
|
[28]KALAITZAKIS E,SADIK R,HOLST JJ,et al.Gut transit is associated with gastrointestinal symptoms and gut hormone profile in patients with cirrhosis[J].Clin Gastroenterol Hepatol,2009,7(3):346-352.
|
|
[29]CHANDER ROLAND B,GARCIA-TSAO G,CIARLEGLIO MM,et al.Decompensated cirrhotics have slower intestinal transit times as compared with compensated cirrhotics and healthy controls[J].J Clin Gastroenterol,2013,47(10):888-893.
|
|
[30]LAVIANO A,CANGIANO C,PREZIOSA I,et al.Plasma tryptophan levels and anorexia in liver cirrhosis[J].Int J Eat Disord,1997,21(2):181-186.
|
|
[31]MIYAJIMA H,NOMURA M,MUGURUMA N,et al.Relationship among gastric motility,autonomic activity,and portal hemodynamics in patients with liver cirrhosis[J].J Gastroenterol Hepatol,2001,16(6):647-659.
|
|
[32]GAIVORONSKII IV,TIKHONOVA LP,CHEPUR SV,et al.Intramural nervous apparatus of jejunum and rectum in experimental portal hypertension[J].Morfologiia,2004,125(3):36-40.
|
|
[33]ZHU JZ,XU QZ,LIU QH.The changes of interstitial cell of Cajal in antrum of rats with liver cirrhosis[J].Chin J Gastroenter Hepatol,2005,14(6):618-620.(in Chinese)朱金照,许其增,刘庆宏.肝硬化大鼠胃窦Cajal间质细胞的变化[J].胃肠病学和肝病学杂志,2005,14(6):618-620.
|
|
[34]USAMI A,MIZUKAMI Y,ONJI M.Abnormal gastric motility in liver cirrhosis:roles of secretin[J].Dig Dis Sci,1998,43(11):2392-2397.
|
|
[35]TANG XD,FAN H,WAN P,et al.Multiple analysis on the gastric impetus associated factors in patients with liver cirrhosis[J].Chin JHepatol,2004,12(3):141-143.(in Chinese)唐晓丹,范红,万平,等.肝硬化患者胃动力多因素相关性研究[J].中华肝脏病杂志,2004,12(3):141-143.
|
DownLoad: